This page contains brief information about selumetinib sulfate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Selumetinib sulfate is approved to treat:
- Neurofibromatosis type 1 (NF1) in children aged 2 years and older who have plexiform neurofibromas that are causing symptoms and cannot be removed by surgery.
Selumetinib sulfate is also being studied in the treatment of other types of cancer.
More About Selumetinib Sulfate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Selumetinib Sulfate - Check for trials from NCI's list of cancer clinical trials now accepting patients.